Company plans increased investment in HCISAfter a six-month search, Picker International has named a new CEO. The multimodality vendor has tapped longtime healthcare executive Fred Parks as its new leader.Parks most recently served as president
Company plans increased investment in HCIS
After a six-month search, Picker International has named a new CEO. The multimodality vendor has tapped longtime healthcare executive Fred Parks as its new leader.
Parks most recently served as president and COO of St. Jude Medical, a Minneapolis-based developer of implantable cardiovascular products. Prior to his stint at St. Jude, Parks held a similar position at EC&G, where he led the growth of the Wellesley, MA-based firms x-ray, CCD, luminometer, and medical diagnostics operations. He spent two decades at EC&G.
In his new post, Parks will report to Michael Donovan, who had been serving as interim CEO, and is CEO of Picker parent General Electric Companys Marconi Systems unit. Parks has big shoes to fill at Picker replacing Cary Nolan, who retired in April (SCAN 4/14/99). At the time of his retirement, Nolan was the longest serving medical imaging chief executive, and the firm doubled in size during his 10-year tenure.
In addition, Parks comes to a company that has been active in the last year in both acquisitions and internal restructuring. Just prior to the 1998 RSNA meeting, the vendor completed its acquisition of Elscints CT division (SCAN 12/16/98).
Earlier this year, Picker also created a new business unit, Picker Medical Systems, which combined the firms equipment, sales, and service operations into one entity (SCAN 4/14/99). Previously, these divisions had operated separately, with different chief executives and lines of reporting.
The company has also formed a dedicated HealthCare Information Systems group, and aggressively added to its Picker Health Care Products distribution arm by buying a number of distributors in recent years (SCAN 2/17/99 and 3/31/99). Most recently, Picker entered the high-end MRI arena with the acquisition of high-field MRI developer Surrey Medical Imaging Systems (SCAN 9/15/99).
These moves are apparently paying off. Picker expects to book record annual financial results this year, Parks said. The company is seeing across-the-board revenue increases, with CT, traditionally the firms strongest product line, continuing to provide leadership.
Going forward, one area of increased focus will be investments in the healthcare information systems arena, according to Parks.
Thats where the market is going, and its a natural move for us, he said.
In addition to the moves it has made, Picker has been the subject of persistent rumors regarding other potential mergers and acquisitions. The rumors heated up earlier this year over comments by GEC chairman George Simpson that the company could be eyeing the medical electronics business of Siemens or Philips (SCAN 2/3/99). GEC was considering using the profits from the sale of its defense businesses to bolster its communications and technology concerns, such as Picker.
Industry observers wondered whether ultrasound vendor Acuson might be a potential target; a deal with that firm would fill a gap in Pickers multimodality portfolio. GECs acquisitions, however, have largely been in the networking and telecommunications realm, easing some of the speculation.
Parks declined to comment on specific companies Picker would consider pursuing, but did say the company does not consider it a priority to diversify into ultrasound. Instead, Picker will be focusing on potential opportunities in the HCIS sector, in a move thats in line with GECs recent activities in networking and telecommunications.
There are some really exciting opportunities in that market, Parks said.
The Reading Room Podcast: Current Perspectives on the Updated Appropriate Use Criteria for Brain PET
March 18th 2025In a new podcast, Satoshi Minoshima, M.D., Ph.D., and James Williams, Ph.D., share their insights on the recently updated appropriate use criteria for amyloid PET and tau PET in patients with mild cognitive impairment.
Contrast-Enhanced Mammography Study Reveals 24 Percent Lower Sensitivity with Moderate/Marked BPE
April 30th 2025In comparison to minimal or mild background parenchymal enhancement on contrast-enhanced mammography (CEM), researchers found that moderate or marked BPE was associated with a 12 percent lower AUC for breast cancer detection.
Study Examines CT-Based AI Detection of Incidental Abdominal Aortic Aneurysms
April 29th 2025The AI software Viz AAA offered a sensitivity of 87.5 percent in detecting abdominal aortic aneurysms on contrast-enhanced CT, according to new retrospective research presented at the American Roentgen Ray Society (ARRS) conference.